GDP (Good Distribution Practice) or GBP (Good distribution practices) is a compendium of regulations and legislation that governs the distribution of active ingredients, medicines for human use and medical devices.
Compliance with GDP regulations throughout the manufacturing and distribution chain in the pharmaceutical industry is what guarantees the adequate quality of medicines for end users.
DEL CORONA & SCARDIGLI SPAIN SLU applies the GDP requirements in its Management System for national and international transport operations. JUMA CONSULTING has certified that DEL CORONA & SCARDIGLI SPAIN SLU has satisfactorily implemented the GDP Management System and therefore complies with the provisions of:
- European Commission Guidelines of 5 November 2013 on good distribution practices for medicinal products for human use (2013/C 343/01) Official Journal of the European Union of 23.11.2013.
- Royal Decree 782/2013, of 11 October, on the distribution of medicines for human use. BOE No. 251 of 19 October 2013.
- Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices.
